Spermosens AB (publ) (NGM: SPERM)
Health Care · Biotechnology · SE
Skr—
— today · — 1Y
Spermosens AB (publ) (NGM: SPERM) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.67M.
trading between 0.00 and 0.01.
Tweenvest scores Spermosens AB (publ) across four factors: quality 57/100, value 63/100. Its strongest factor is value.
SPERM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.67M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.15
- 52-week high
- Skr0.01
- 52-week low
- Skr0.00
- Avg volume (3M)
- —
- Shares outstanding
- 3.17B
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| HCW Biologics Inc.NasdaqCM: HCWB | $2.77M | $1.24 | -22.50% |
| Modus Therapeutics Holding AB (publ)OM: MODTX | $2.76M | Skr0.18 | -52.45% |
| Vaccinex, Inc.OTCPK: VCNX | $2.69M | $1.01 | -11.81% |
| Bioxytran, Inc.OTCPK: BIXT | $2.67M | $0.02 | +1.75% |
| VivoSim Labs, Inc.NasdaqCM: VIVS | $2.60M | $0.16 | -12.88% |
| ExpreS2ion Biotech Holding AB (publ)OM: EXPRS2 | $2.47M | Skr1.03 | -5.50% |
| Ocean Sciences LtdASX: OSS | $2.46M | AU$0.02 | +15.38% |
| Enzolytics, Inc.OTCPK: ENZC | $2.42M | $0.00 | +11.11% |
Figures last refreshed Oct 18, 2026.